Reference : Using prior knowledge from cellular pathways and molecular networks for diagnostic sp...
Scientific journals : Article
Life sciences : Biotechnology
Life sciences : Biotechnology
Life sciences : Multidisciplinary, general & others
Physical, chemical, mathematical & earth Sciences : Multidisciplinary, general & others
Human health sciences : Multidisciplinary, general & others
http://hdl.handle.net/10993/21843
Using prior knowledge from cellular pathways and molecular networks for diagnostic specimen classification
English
Glaab, Enrico mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > >]
2-Jul-2015
Briefings in Bioinformatics
Oxford University Press
1-13
Yes (verified by ORBilu)
International
1467-5463
1477-4054
[en] biomarker ; pathway analysis ; network analysis ; machine learning ; omics ; cross-study analysis ; prediction ; supervised learning ; dagnostics ; biostatistics ; classification ; prognosis
[en] For many complex diseases, an earlier and more reliable diagnosis is considered a key prerequisite for developing more effective therapies to prevent or delay disease progression. Classical statistical learning approaches for specimen classification using omics data, however, often cannot provide diagnostic models with sufficient accuracy and robustness for heterogeneous diseases like cancers or neurodegenerative disorders. In recent years, new approaches for building multivariate biomarker models on omics data have been proposed, which exploit prior biological knowledge from molecular networks and cellular pathways to address these limitations. This survey provides an overview of these recent developments and compares pathway- and network-based specimen classification approaches in terms of their utility for improving model robustness, accuracy and biological interpretability. Different routes to translate omics-based multifactorial biomarker models into clinical diagnostic tests are discussed, and a previous study is presented as example.
Luxembourg Centre for Systems Biomedicine (LCSB): Biomedical Data Science (Enrico Glaab) ; Luxembourg Centre for Systems Biomedicine (LCSB): Bioinformatics Core (R. Schneider Group)
Fonds National de la Recherche - FnR
Researchers ; Professionals ; Students
http://hdl.handle.net/10993/21843
10.1093/bib/bbv044
http://bib.oxfordjournals.org/content/early/2015/07/02/bib.bbv044.full
FnR ; FNR5782168 > Enrico Glaab > ExPDIENT > Exploring Parkinson’s Disease Inhibitor Efficacy on a Non-dopaminergic Target > 01/12/2013 > 31/05/2016 > 2013

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Brief Bioinform-2015-Glaab-bib-bbv044.pdfPublisher postprint406.01 kBView/Open

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.